AN H3 RECEPTOR ANTAGONIST COMBINED WITH A CHOLINESTERASE INHIBITOR FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE

摘要

The present disclosure relates to a compound 2- (cyclohexylmethyl) -N- {2- [(2S) -1-methylpyrrolidin-2-yl] ethyl} -1 , 2,3,4-tetrahydroisoquinoline-7-sulfonamide or a pharmaceutically acceptable salt thereof.